Back to Search
DOUG FRYE, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1780647495IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
0422923(KS)
Education
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Class of 1982
Research & Publications (20)
Phase I study of prolonged-infusion gemcitabine combined with cyclophosphamide in patients with metastatic carcinoma of the breast: tolerability of an optimal dose schedule.
PMID 19556811·Oncology·2009
3-trial
Capecitabine-based combination therapy for breast cancer: implications for nurses.
PMID 19136344·Oncol Nurs Forum·2009
6-review
Neonatal and maternal outcomes associated with elective term delivery.
PMID 19110225·Am J Obstet Gynecol·2009
4-observational
Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer.
PMID 19073507·Clin Breast Cancer·2008
3-trial
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.
PMID 17468948·Breast Cancer Res Treat·2008
8-other
Demographic characteristics and sexual behaviors associated with methamphetamine use among MSM and non-MSM diagnosed with AIDS in Los Angeles County.
PMID 17968649·AIDS Behav·2008
8-other
Increases in noninjection methamphetamine use in men who have sex with men, men who do not have sex with men, and Latino men diagnosed with AIDS in Los Angeles County, 2000 through 2004.
PMID 17704687·J Acquir Immune Defic Syndr·2007
8-other
Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes.
PMID 17980181·Am J Obstet Gynecol·2007
8-other
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.
PMID 17293601·Ann Oncol·2007
3-trial
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
PMID 17009032·Cancer Chemother Pharmacol·2007
3-trial
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
PMID 16639731·Cancer·2006
2-rct
Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer.
PMID 16193332·Cancer Chemother Pharmacol·2006
3-trial
Concerns about article on code-versus-name reporting of HIV.
PMID 17003674·J Acquir Immune Defic Syndr·2006
8-other
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.
PMID 15738535·J Clin Oncol·2005
3-trial
Multistate outbreak of Listeria monocytogenes infection linked to delicatessen turkey meat.
PMID 15824987·Clin Infect Dis·2005
7-preclinical
High incidence of HIV-associated mortality among black and Hispanic infants and women of childbearing age in the United States 1990-2001.
PMID 16010175·J Acquir Immune Defic Syndr·2005
8-other
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.
PMID 16087943·J Clin Oncol·2005
3-trial
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.
PMID 15197190·J Clin Oncol·2004
3-trial
Recent increase in high-risk sexual behaviors among sexually active men who have sex with men living with AIDS in Los Angeles County.
PMID 14722458·J Acquir Immune Defic Syndr·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5000 SW 21ST ST
TOPEKA, KS 66604 - Phone
- (785) 271-8100
Quick Facts
- NPI
- 1780647495
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile